A detailed history of Providence First Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Providence First Trust CO holds 2,357 shares of LLY stock, worth $1.76 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
2,357
Previous 909 159.3%
Holding current value
$1.76 Million
Previous $822,000 154.01%
% of portfolio
0.9%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $1.12 Million - $1.39 Million
1,448 Added 159.3%
2,357 $2.09 Million
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $579,896 - $727,232
-800 Reduced 46.81%
909 $822,000
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $733,735 - $981,634
1,239 Added 263.62%
1,709 $1.33 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $246,839 - $290,991
470 New
470 $273,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Providence First Trust CO Portfolio

Follow Providence First Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence First Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Providence First Trust CO with notifications on news.